Showing results (1-10 of 149) with videos related to
Sort By:
Pageof 15
Current Infectious Disease Reports|August 31, 2013
The Surviving Sepsis Campaign's Revised Sepsis BundlesAmisha V Barochia, Xizhong Cui, Peter Q EichackerAmerican Journal of Respiratory and Critical Care Medicine|November 11, 2006
Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapyKevin Sherer, Yan Li, Xizhong Cui, et al.Expert Opinion on Biological Therapy|June 9, 2007
New insights into the pathogenesis and treatment of anthrax toxin-induced shockYan Li, Kevin Sherer, Xizhong Cui, et al.Expert Opinion on Drug Metabolism & Toxicology|February 18, 2011
Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studiesAmisha Barochia, Steven Solomon, Xizhong Cui, et al.Intensive Care Medicine|August 9, 2007
Neuronal nitric oxide synthase deficiency decreases survival in bacterial peritonitis and sepsisXizhong Cui, Virginia Besch, Alfia Khaibullina, et al.Expert Opinion on Investigational Drugs|April 30, 2015
An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsisLernik Ohanjanian, Kenneth E Remy, Yan Li, et al.BMC Medicine|October 11, 2013
B. anthracis associated cardiovascular dysfunction and shock: the potential contribution of both non-toxin and toxin componentsKenneth E Remy, Ping Qiu, Yan Li, et al.Toxins|December 7, 2017
The Potential Pathogenic Contributions of Endothelial Barrier and Arterial Contractile Dysfunction to Shock Due to B. anthracis Lethal and Edema ToxinsDante A Suffredini, Xizhong Cui, Wanying Xu, et al.American Journal of Respiratory and Critical Care Medicine|August 20, 2011
Anthrax infectionDaniel A Sweeney, Caitlin W Hicks, Xizhong Cui, et al.Intensive Care Medicine|April 25, 2012
An overview of anthrax infection including the recently identified form of disease in injection drug usersCaitlin W Hicks, Daniel A Sweeney, Xizhong Cui, et al.Pageof 15